Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual General Meeting

Transgene Biotek Annual General Meeting

Transgene Biotek has received ROC approval to extend its 36th AGM deadline by three months. The meeting for FY2025-26 will now be held by December 31, 2026.

Source

BSE filing, NSE: TRABI. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Transgene Biotek Ltd: key numbers

Share price
₹2.36
Market cap
₹17.88 Cr
Revenue (annual)
₹0.21 Cr
Net profit (annual)
₹-1.65 Cr
P/E (TTM)
-11.1×Sector 52.0×
Promoter holding
23.64%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Transgene Biotek Ltd

All →

Other annual general meeting announcements

All →